TrialSignal
Clinical trial intelligence report
Development of a Novel, Safe Method for the Non-invasive Assessment of Human Bone Quality, In Vivo, Using Spatially Offset Raman Spectroscopy
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT02814591
Status
UNKNOWN
Phase
N/A
Sponsor
University College, London
Executive brief
Investment-Ready Snapshot
In this study spatially offset Raman spectroscopy (SORS), which allows the collection of Raman spectra through turbid media, is being applied to collect Raman spectra of bone. The principal aim to find ways to use Raman spectroscopy to assess bone quality in vivo.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02814591
Indication
Osteoarthritis
Modality
medical device
Target
spatially offset Raman spectrometer (SORS)
Intervention
spatially offset Raman spectrometer (SORS)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.